Chison Medical Financials
| 688358 Stock | 31.42 0.23 0.74% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 97.4 M | 150.7 M |
|
|
Chison | Select Account or Indicator |
Understanding current and past Chison Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chison Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Chison Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Chison Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chison Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chison Medical's management manipulating its earnings.
Chison Medical Stock Summary
Chison Medical competes with BlueFocus Communication, China Sports, Shenzhen AV-Display, Qingdao Hi, and Everdisplay Optronics. Chison Medical is entity of China. It is traded as Stock on SHG exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
You should never invest in Chison Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Chison Stock, because this is throwing your money away. Analyzing the key information contained in Chison Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Chison Medical Key Financial Ratios
Chison Medical's financial ratios allow both analysts and investors to convert raw data from Chison Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Chison Medical over time and compare it to other companies across industries.| Revenue | 483.84 M | ||||
| EBITDA | 125.83 M | ||||
| Net Income | 146.48 M | ||||
| Total Asset | 1.52 B | ||||
| Retained Earnings | 305.98 M |
Chison Medical Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 1.4B | 1.4B | 1.5B | 1.5B | 1.8B | 1.1B | |
| Retained Earnings | 146.8M | 188.2M | 241.7M | 306.0M | 351.9M | 369.5M | |
| Accounts Payable | 73.2M | 80.3M | 128.0M | 84.6M | 97.3M | 70.4M | |
| Cash | 302.0M | 445.9M | 446.2M | 688.8M | 792.1M | 442.7M | |
| Net Receivables | 126.1M | 135.8M | 93.5M | 154.5M | 177.7M | 101.2M | |
| Inventory | 84.1M | 99.5M | 197.0M | 135.9M | 156.3M | 99.2M | |
| Other Current Assets | 7.2M | 5.0M | 15.1M | 12.9M | 11.6M | 9.2M | |
| Total Liab | 158.5M | 152.5M | 200.4M | 153.4M | 176.4M | 147.0M | |
| Total Current Assets | 1.3B | 1.3B | 1.3B | 1.3B | 1.5B | 967.1M | |
| Intangible Assets | 23.8M | 22.5M | 22.1M | 21.1M | 24.2M | 16.6M | |
| Other Current Liab | 3.4M | 2.8M | 500.7K | 22.6K | 20.3K | 19.3K | |
| Net Invested Capital | 1.2B | 1.2B | 1.3B | 1.4B | 1.6B | 1.0B | |
| Net Working Capital | 1.1B | 1.1B | 1.2B | 1.2B | 1.4B | 953.2M |
Chison Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 11.9M | 12.1M | 9.3M | 15.7M | 18.1M | 11.9M | |
| Net Interest Income | 928.6K | 2.1M | 2.1M | 18.2M | 21.0M | 22.0M | |
| Interest Expense | (1.2M) | (2.4M) | (2.3M) | (18.6M) | (16.8M) | (15.9M) | |
| Total Revenue | 333.1M | 397.8M | 380.8M | 483.8M | 556.4M | 375.5M | |
| Gross Profit | 195.1M | 223.9M | 225.8M | 284.5M | 327.2M | 221.6M | |
| Operating Income | 90.5M | 86.7M | 77.8M | 131.0M | 150.7M | 97.4M | |
| Research Development | 55.6M | 72.3M | 77.9M | 77.1M | 88.6M | 60.2M | |
| Cost Of Revenue | 138.0M | 173.9M | 155.1M | 199.3M | 229.2M | 153.9M | |
| Income Before Tax | 111.5M | 124.5M | 115.1M | 162.2M | 186.5M | 116.3M | |
| Net Income | 99.6M | 112.5M | 105.8M | 146.5M | 168.5M | 104.4M | |
| Interest Income | (605.2K) | (2.5M) | (2.4M) | (19.0M) | (17.1M) | (16.2M) | |
| Ebitda | 124.1M | 118.5M | 132.0M | 125.8M | 144.7M | 127.8M |
Chison Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Chison Medical Techn. It measures of how well Chison is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Chison Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Chison had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Chison Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (25.4M) | (16.8M) | (100.4M) | 56.1M | 50.5M | 53.0M | |
| Investments | (748.6M) | 164.1M | (45.4M) | (241.2M) | (217.1M) | (206.2M) | |
| Change In Cash | (761.0M) | 136.4M | 990.4K | (235.5M) | (211.9M) | (201.3M) | |
| Depreciation | 8.2M | 9.9M | 13.0M | 14.3M | 16.4M | 9.3M | |
| Dividends Paid | 80M | 64M | 40M | 78.5M | 90.3M | 55.8M | |
| Capital Expenditures | 30.9M | 39.2M | 52.2M | 34.0M | 39.1M | 26.3M | |
| Total Cash From Operating Activities | 82.4M | 40.0M | 63.7M | 85.9M | 98.8M | 72.6M | |
| Net Income | 99.6M | 112.5M | 105.8M | 146.5M | 168.5M | 104.4M | |
| End Period Cash Flow | 302.0M | 438.5M | 439.5M | 204.0M | 234.6M | 374.0M | |
| Free Cash Flow | 51.6M | 775.6K | 11.5M | 51.9M | 46.7M | 34.5M | |
| Change In Working Capital | (5.2M) | (44.8M) | (23.9M) | (42.3M) | (38.1M) | (40.0M) | |
| Begin Period Cash Flow | 1.1B | 302.0M | 438.5M | 439.5M | 505.4M | 395.4M | |
| Other Non Cash Items | 3.8M | 3.3M | (21.3M) | (22.2M) | (20.0M) | (19.0M) |
Chison Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chison Medical's current stock value. Our valuation model uses many indicators to compare Chison Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chison Medical competition to find correlations between indicators driving Chison Medical's intrinsic value. More Info.Chison Medical Technologies is the top company in current valuation category among its peers. It also is number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for Chison Medical Technologies is about 960,197,935 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chison Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chison Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Chison Medical Techn Systematic Risk
Chison Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chison Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Chison Medical Techn correlated with the market. If Beta is less than 0 Chison Medical generally moves in the opposite direction as compared to the market. If Chison Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chison Medical Techn is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chison Medical is generally in the same direction as the market. If Beta > 1 Chison Medical moves generally in the same direction as, but more than the movement of the benchmark.
Chison Medical Technologies Total Assets Over Time
Chison Medical Thematic Clasifications
Chison Medical Technologies is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Chison Medical March 28, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Chison Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chison Medical Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chison Medical Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Chison Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chison Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.08 | |||
| Information Ratio | 0.0914 | |||
| Maximum Drawdown | 31.39 | |||
| Value At Risk | (3.75) | |||
| Potential Upside | 6.79 |
Complementary Tools for Chison Stock analysis
When running Chison Medical's price analysis, check to measure Chison Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chison Medical is operating at the current time. Most of Chison Medical's value examination focuses on studying past and present price action to predict the probability of Chison Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chison Medical's price. Additionally, you may evaluate how the addition of Chison Medical to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |